Skip to main content
Top

Drugs

Issue 4/2013

Content (8 Articles)

LDL Cholesterol Goals in High-Risk Patients: How Low Do We Go and How Do We Get There?

  • Current Opinion

Joost Besseling, Julian van Capelleveen, John J. P. Kastelein, G. Kees Hovingh

Promising New Molecular Targeted Therapies in Head and Neck Cancer

  • Leading Article

Kelly Dorsey, Mark Agulnik

Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management

  • Therapy in Practice

Joe M. Chehade, Margaret Gladysz, Arshag D. Mooradian

Targeting Interleukin-6 in Rheumatoid Arthritis

  • Review Article

Md Yuzaiful Md Yusof, Paul Emery

First-Line Management of EGFR-Mutated Advanced Lung Adenocarcinoma: Recent Developments

  • Review Article

Bin-Chi Liao, Chia-Chi Lin, James Chih-Hsin Yang

Lixisenatide: First Global Approval

  • R&D INSIGHT REPORT

Shelley Elkinson, Gillian M. Keating

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images